Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinoma. [electronic resource] by
- Mayer, E L
- DeMichele, A
- Rugo, H S
- Miller, K
- Waks, A G
- Come, S E
- Mulvey, T
- Jeselsohn, R
- Overmoyer, B
- Guo, H
- Barry, W T
- Huang Bartlett, C
- Koehler, M
- Winer, E P
- Burstein, H J
Producer: 20200603
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 30
Availability: No items available.
|
|
14.
|
Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer. [electronic resource] by
- Waks, A G
- Cohen, O
- Kochupurakkal, B
- Kim, D
- Dunn, C E
- Buendia Buendia, J
- Wander, S
- Helvie, K
- Lloyd, M R
- Marini, L
- Hughes, M E
- Freeman, S S
- Ivy, S P
- Geradts, J
- Isakoff, S
- LoRusso, P
- Adalsteinsson, V A
- Tolaney, S M
- Matulonis, U
- Krop, I E
- D'Andrea, A D
- Winer, E P
- Lin, N U
- Shapiro, G I
- Wagle, N
Producer: 20210106
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 31
Availability: No items available.
|